Metraipolis › archive › dc_99b7dafed2f5
Dimeric CCK2R radiotheranostic tracers synergize with mTOR inhibition for enhanced tumor therapy — Europe PMC PMID:40963930
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40963930
- DOI
- 10.7150/thno.117021
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T03:10:27.474Z
- SHA-256 of the archived text
ed7c1dbd36e844976569fce0e7a3dc6b3788ce619814dd967733fb3a517147e6- Stable URL of this page
https://metraipolis.com/documento/dc_99b7dafed2f5
How to cite
Dimeric CCK2R radiotheranostic tracers synergize with mTOR inhibition for enhanced tumor therapy — Europe PMC PMID:40963930 — Europe PMC (en), https://europepmc.org/article/MED/40963930 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_99b7dafed2f5 (Metraipolis archive dc_99b7dafed2f5, sha256 ed7c1dbd36e844976569fce0e7a3dc6b3788ce619814dd967733fb3a517147e6)
BibTeX
@misc{dc99b7dafed2f5,
title = {Dimeric CCK2R radiotheranostic tracers synergize with mTOR inhibition for enhanced tumor therapy — Europe PMC PMID:40963930},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40963930},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_99b7dafed2f5; sha256 ed7c1dbd36e844976569fce0e7a3dc6b3788ce619814dd967733fb3a517147e6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40963930. Agents can read the archived copy with the MCP tool read_document.